Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations. The Company also manufactures intravenous (IV) Fluids. It offers products in various categories, including IV fluids, oncology, anesthesia and exports. Its IV Fluids include Carbohydrated and Electrolytes, such as Dextrose IP 25%, Ringer Lactate IP, and Multiple Eletrolytes and Dextrose Injection IP Type I; Diuretics, such as Mannitol 10%, 20%; Dialysis and Irrigation Solution, such as Peritoneal Dialysis Solution with 1.7% Dextrose; Anti-infective and Anti-fungal, such as Ciprofloxacin 200mg, and Others, such as Tamolgan (Paracetamol 1000mg). Its Oncology product mix includes 5 FU-PAR, BLEOPAR, BOTEPAR and BAZIPAR. Its Anesthesia product mix includes Sevoplan (Sevoflurane 100/250ml) and Isoplan (Isoflurane 100/250ml). Its exports products include CIPROFLOXACIN INJECTION USP WITH DEXTROSE and FLUCONAZOLE INJECTION USP.